Commonest carcinoma in men in tropical countries is
Sandfly acts as a vector to all of the following diseases, except which of the following?
Which of the following statements about carriers of infectious diseases is true?
Which of the following is a distinguishing feature of Aedes mosquitoes compared to Anopheles mosquitoes?
Which measure is most appropriate for assessing the infectivity of an organism?
Which of the following is a disadvantage of non-randomized trials?
Repetition of a study in a given group is known as:
In which months does the maximum spread of malaria typically occur in many endemic regions of India?
In a cohort study conducted with 100 individuals in each group (exposed and non-exposed), out of those exposed to the risk factor, 10 are diseased, and out of those not exposed to the risk factor, only 5 are diseased. What is the relative risk?
Which of the following statements about the Urban Malaria Scheme is incorrect?
Explanation: ***Ca oral cavity*** - The high prevalence of **tobacco chewing** and **betel nut use** in many tropical countries significantly contributes to the high incidence of oral cavity cancer in men. - This habit is deeply ingrained in the **cultural practices** of these regions, leading to chronic irritation and carcinogenesis. *Ca rectum* - While colorectal cancer is common globally, it is generally **less prevalent** in tropical regions compared to oral cavity cancers attributed to specific lifestyle factors. - Its incidence is often linked to **Westernized diets** and sedentary lifestyles, which are not universally dominant in all tropical areas. *Ca testis* - Testicular cancer is more common in **younger men** in developed countries and is not typically the leading cancer in men across tropical regions. - It accounts for a **smaller proportion** of all male cancers globally compared to more prevalent cancers like oral cavity, lung, or prostate cancer. *Ca bladder* - Bladder cancer is often associated with **smoking** and occupational exposure to certain chemicals (e.g., dyes, rubber). - While present, it does not typically surpass the incidence of **oral cavity cancer** in tropical regions, where unique risk factors are highly prevalent.
Explanation: ***Onchocerciasis*** - **Onchocerciasis**, or river blindness, is transmitted by the **blackfly (Simulium species)**, not the sandfly. - The disease is caused by the filarial nematode *Onchocerca volvulus*, which is introduced into humans through the bite of an infected blackfly. *Pappataci fever* - **Pappataci fever**, also known as sandfly fever, is a viral disease transmitted by the bite of infected **sandflies (Phlebotomus species)**. - This disease is characterized by a sudden onset of fever, headache, and muscle pain. *Kala-azar* - **Kala-azar**, or visceral leishmaniasis, is a severe form of **leishmaniasis** transmitted by the bite of an infected female **sandfly (Phlebotomus species)**. - It is caused by intracellular parasites of the genus *Leishmania* and affects internal organs. *Leishmaniasis* - **Leishmaniasis** in its various forms (cutaneous, mucocutaneous, visceral) is transmitted by the bite of an infected female **sandfly**. - The sandfly acts as the definitive host and vector for the *Leishmania* parasites.
Explanation: **_Carriers serve as a source of infection._** - A **carrier** is an individual who harbors an infectious agent without showing apparent clinical signs of the disease but can transmit it to others. - Their ability to transmit the pathogen makes them an important **source of infection** within a population. *Carriers can show clinical symptoms of infection.* - By definition, carriers do not exhibit **clinical symptoms** of the disease, although they may be infected. - If symptoms were present, the individual would be considered a **symptomatic case**, not a carrier. *Carriers are more infectious than symptomatic cases.* - The infectiousness of a carrier varies depending on the specific pathogen and host factors, but they are generally considered **less infectious** than symptomatic cases who are actively shedding high loads of pathogens. - **Symptomatic individuals** often shed pathogens more robustly due to active disease processes, leading to higher transmission rates. *Carriers are less dangerous than symptomatic cases.* - While carriers may show no symptoms and often shed fewer pathogens than symptomatic cases, they can be particularly **dangerous** because they can transmit the disease unknowingly and without protective measures. - Their **undetected transmission** contributes significantly to the spread of infectious diseases, especially in the early stages of an outbreak.
Explanation: ***Wings unspotted*** - **Aedes mosquitoes have unspotted wings**, which is a key distinguishing feature for adult identification. - *Anopheles* mosquitoes characteristically have **spotted wings** with patches of dark and pale scales, making this a reliable diagnostic criterion. - This is one of the most practical features for field identification of adult mosquitoes. *Pupa has a narrow siphon* - This is **incorrect** - *Aedes* pupae actually have a **broad and short respiratory siphon (trumpet)**. - *Anopheles* pupae have a **narrow and long siphon**, which is the opposite of what this option states. - Pupal characteristics are useful but require microscopic examination. *Pupa has broad siphon* - While *Aedes* pupae do have a **broader siphon** compared to *Anopheles*, this is less commonly used for routine identification. - The broad siphon refers to the respiratory trumpet structure at the cephalothorax. - However, **wing spotting pattern** remains the preferred adult identification method. *Eggs are oval shaped* - *Aedes* eggs are **oval/elongated and laid singly**, often on moist surfaces above the waterline. - *Anopheles* eggs are also **boat-shaped with lateral floats** and laid singly on the water surface. - Both genera have oval-shaped eggs, making this a less reliable distinguishing feature alone.
Explanation: ***Secondary attack rate*** - This measure directly quantifies the **proportion of susceptible contacts** who develop the disease after exposure to a primary case, making it ideal for assessing **infectivity**. - A higher secondary attack rate indicates a more **highly transmissible** organism. *Prevalence rate* - This measures the **total number of existing cases** in a population at a specific time or over a period, reflecting the overall burden of disease. - It does not specifically indicate how easily an organism spreads from one person to another. *Case fatality rate* - This represents the **proportion of individuals diagnosed with a disease** who ultimately die from that disease. - It measures the **severity or virulence** of an infection, not its infectivity. *Incidence rate* - This measures the **rate at which new cases of a disease occur** in a population over a specified period. - While it reflects disease occurrence, it doesn't specifically assess the likelihood of transmission from an infected individual to their contacts.
Explanation: ***Degree of comparability is low*** - Non-randomized trials have a **lower degree of comparability** between intervention and control groups because subjects are not randomly assigned, making it more difficult to attribute observed differences solely to the intervention. - This lack of comparability increases the risk of **confounding variables** influencing the results, as baseline characteristics of the groups may differ significantly. *Random assignment of subjects* - This is a *feature of randomized controlled trials (RCTs)*, not a disadvantage of non-randomized trials. RCTs use random assignment to create comparable groups. - In non-randomized trials, **random assignment is absent**, which is precisely why comparability can be low. *The experiment can serve as its own control or can utilize a natural control* - This describes a potential **advantage or characteristic of certain non-randomized designs**, like before-and-after studies or natural experiments. - While it can be useful in some contexts, it does not mitigate the fundamental issue of **low comparability** in non-randomized designs when comparing different groups. *Several trials may be needed before evaluation is considered conclusive.* - This statement applies broadly to many types of research, including some randomized trials, and indicates the need for **replication and robust evidence**. - While non-randomized trials might indeed require more supportive evidence due to their inherent limitations, this is a general research principle and not a unique disadvantage stemming from non-randomization itself, compared to the direct impact on comparability.
Explanation: ***Panel study*** - A **panel study** is the epidemiological term for a longitudinal study design where the **same group of individuals is studied repeatedly** over time. - This directly answers the question: "repetition of a study in a given group" is known as a **panel study**. - The same panel (group) of subjects is examined or surveyed at multiple time points, allowing researchers to track changes within individuals over time. - Common in epidemiological research, social sciences, and health surveys (e.g., National Family Health Survey panels). *Repeated measures design (statistical)* - This term refers to a **statistical analysis technique** rather than a study design or research methodology. - While it involves analyzing data with multiple measurements from the same subjects, it is not what "repetition of a study in a given group" is called in epidemiological terminology. - It describes the statistical approach used to analyze such data, not the study design itself. *Cohort study* - A **cohort study** follows a group over time to assess the **incidence of disease or outcomes** and identify risk factors. - The focus is on comparing exposed vs. unexposed groups or following a cohort to observe new outcomes, not specifically on "repeating a study" in the same group. - While longitudinal, the term doesn't specifically denote repetition of measurements in the same individuals. *Cross-sectional study* - A **cross-sectional study** collects data at a **single point in time** to assess prevalence. - It provides a snapshot and involves **no repetition** over time, making it incorrect for this question.
Explanation: ***September-October*** - The **peak transmission** season for **malaria** in many endemic regions of India occurs during the **post-monsoon** months. - This period provides optimal conditions for **mosquito breeding** due to accumulated water collections, moderate temperatures, and suitable humidity levels after the monsoon rains. - **Post-monsoon months** allow for maturation of mosquito populations that bred during monsoon, leading to maximum vector density and malaria transmission. *April-May* - These **pre-monsoon** months may show increased transmission in some regions, but this is **not the universal peak period** across India. - The preceding dry season usually means **fewer breeding sites** compared to post-monsoon period. - Temperatures are rising but **water collections are limited** before monsoon onset. *January-February* - These months typically represent the **winter season** in most parts of India where malaria is endemic. - **Lower temperatures** and reduced humidity are generally unfavorable for the survival of the *Anopheles* mosquito and the development of the *Plasmodium* parasite within the mosquito. - This represents the **lowest transmission period** in most endemic areas. *March-April* - While malaria transmission may begin to increase in these months, it generally **peaks later** after monsoon rains create abundant breeding sites. - The dry season conditions still prevail, limiting **vector breeding opportunities** compared to post-monsoon months.
Explanation: ***Correct Option: 2*** - The **incidence in the exposed group** is 10/100 = 0.1. - The **incidence in the non-exposed group** is 5/100 = 0.05. - **Relative risk (RR)** is calculated as the ratio of the incidence in the exposed group to the incidence in the non-exposed group: 0.1 / 0.05 = 2. - This indicates that the **exposed group has twice the risk** of developing the disease compared to the non-exposed group. *Incorrect Option: 1.5* - This value would be obtained if the ratio of incidences was 0.075 / 0.05 or 0.1/0.066, which is not consistent with the given data. - An RR of 1.5 indicates a **lesser strength of association** than what is observed in this study. *Incorrect Option: 0.75* - This value would result if the incidence in the exposed group was *lower* than in the non-exposed group (e.g., 0.05 / 0.066), suggesting a **protective effect**. - An RR < 1 implies that exposure is protective rather than a risk factor, which contradicts the given data. *Incorrect Option: 1* - A **relative risk of 1** indicates there is no difference in the risk of disease between the exposed and non-exposed groups. - This would mean the incidence rate in both groups is identical (e.g., 0.1 / 0.1 = 1), which contradicts the provided data where exposed group has higher incidence.
Explanation: ***It is done in town/city with minimum 50,000 population*** - This statement is **INCORRECT** because it misrepresents the eligibility criteria for the Urban Malaria Scheme. - The actual criterion is not based solely on a minimum population threshold; rather, the scheme is implemented in **towns and cities classified as urban areas** as per Census of India definitions, which may vary. - While many urban centers targeted have populations around or exceeding 50,000, the program focuses on **malaria endemicity and urban characteristics** rather than a fixed population cutoff. *Utilization of anti-larva measures* - This is a **CORRECT** statement about the Urban Malaria Scheme. - Anti-larval measures are a cornerstone of the program, including **source reduction, larvicides, and biological control** of mosquito breeding sites. - Urban environments have specific breeding sites (construction sites, overhead tanks, etc.) that require targeted anti-larval interventions. *Introduction of active surveillance* - This is a **CORRECT** statement about the Urban Malaria Scheme. - **Active case detection** through fever surveys and surveillance is a key component for early identification and treatment of malaria cases. - Active surveillance helps prevent outbreaks in densely populated urban areas. *Slide positivity rate more than 10%* - This is a **CORRECT** statement about the Urban Malaria Scheme. - Areas with **Slide Positivity Rate (SPR) ≥ 10%** are prioritized for intensive interventions under the scheme. - High SPR indicates active transmission and helps identify high-burden urban pockets requiring focused control measures.
Principles of Epidemiology
Practice Questions
Measures of Disease Frequency
Practice Questions
Epidemiological Study Designs
Practice Questions
Descriptive Epidemiology
Practice Questions
Analytical Epidemiology
Practice Questions
Experimental Epidemiology
Practice Questions
Screening for Disease
Practice Questions
Surveillance Systems
Practice Questions
Investigation of an Epidemic
Practice Questions
Association and Causation
Practice Questions
Modern Epidemiological Methods
Practice Questions
Critical Appraisal of Epidemiological Studies
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free